Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Journal of Neuro-Oncology|January 8, 2015
Neuropeptides of the VIP family inhibit glioblastoma cell invasionStéphanie Cochaud, Annie-Claire Meunier, Arnaud Monvoisin, et al.
Neuropeptides|July 20, 2010
The vasoactive intestinal peptide-receptor system is involved in human glioblastoma cell migrationStéphanie Cochaud, Lucie Chevrier, Annie-Claire Meunier, et al.
International Journal of Pharmaceutics|April 4, 2003
Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to ratsChristine Dufes, Jean-Christophe Olivier, Frédéric Gaillard, et al.
The Journal of Endocrinology|June 27, 2007
Lack of vasoactive intestinal peptide reduces testosterone levels and reproductive aging in mouse testisArnaud Lacombe, Vincent Lelievre, Charles E Roselli, et al.
British Journal of Pharmacology|January 28, 2004
Activation of VPAC1 receptors by VIP and PACAP-27 in human bronchial epithelial cells induces CFTR-dependent chloride secretionRenaud Dérand, Alicia Montoni, Laurence Bulteau-Pignoux, et al.
Peptides|June 9, 2007
Unconventional binding sites and receptors for VIP and related peptides PACAP and PHI/PHM: an updateJean-Marc Muller, Colin Debaigt, Stéphanie Goursaud, et al.
Pharmaceutical Research|February 27, 2004
Anticancer drug delivery with transferrin targeted polymeric chitosan vesiclesChristine Dufes, Jean-Marc Muller, William Couet, et al.
International Journal of Pharmaceutics|October 19, 2004
Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brainChristine Dufes, Frederic Gaillard, Ijeoma F Uchegbu, et al.
Pageof 4